Vesa Antero Nieminen
- Reg. Nr.
- 16258812
- Since
- 2026. gada 23. marts
- Revenue
- €0
- Profit
- €-4328
- Reg. Nr.
- 14374572
- Ownership
- 25.0%
- Since
- 2026. gada 23. marts
- Employees
- 3
- Reg. Nr.
- 16445276
- Ownership
- 50.0%
- Since
- 2026. gada 23. marts
- Revenue
- €112 481
- Profit
- €71 563
Appointed — Officer — Juhatuse liige
EstLend OÜ
Appointed — Officer — Juhatuse liige
Nordicleads OÜ
Appointed — Officer — Juhatuse liige
Otus OÜ
Appointed — Shareholder
Nordicleads OÜ
Appointed — Shareholder
Otus OÜ
Appointed — roles.founder — Asutaja
Otus OÜ
Who does Vesa Antero Nieminen do business with?
Vesa Antero Nieminen shares companies with 6 other people, including Karl David Oz Carlsson Linden, Cecilia Carola Magdalena Linden, Gábor Dániel Czifra, Lauri Petteri Monni, Felix Oliver Maximiliam Landgren and 1 more.
What companies does Vesa Antero Nieminen own or manage?
Vesa Antero Nieminen is linked to 3 active companies including EstLend OÜ, Nordicleads OÜ, Otus OÜ.
What roles does Vesa Antero Nieminen hold in business?
Vesa Antero Nieminen holds 3 officer positions, 1 roles.founder position, 2 shareholder positions, 2 beneficial owner positions across 3 companies.
What is Vesa Antero Nieminen's business ranking?
Vesa Antero Nieminen is ranked #32 259 out of 237 712 business owners, placing in the top 13.6%.
When did Vesa Antero Nieminen first appear in the business registry?
The earliest known registry record for Vesa Antero Nieminen is from 2022-02-17, when they were registered as roles.founder at Otus OÜ.
What is the total revenue of Vesa Antero Nieminen's companies?
The combined revenue of Vesa Antero Nieminen's active companies is approximately €112 481, with 3 employees across all entities.
Is Vesa Antero Nieminen on any sanctions or watchlist?
No — Vesa Antero Nieminen does not appear on any of the sanctions or watchlists we screen against: international sanctions, politically exposed persons (PEP), criminal watchlists, and debarment lists, sourced from OpenSanctions (covering OFAC, EU, UN, UK HMT and similar).